Clinical Trials

A Phase 1/2a Study of BMS-986178 Administered Alone and in Combination With Nivolumab or Ipilimumab in Advanced Solid Tumors


Study ID
Bristol-Myers Squibb CA012-004

NCT Number
NCT02737475 (Click on the NCT number for more information about the trial)

Research Study Number
2016-0273

Principle Investigator
Dr. Martin Gutierrez

Phase
I/II

Sponsor
Bristol-Myers Squibb


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now